Cargando…
SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta
SMER28 (Small molecule enhancer of Rapamycin 28) is an autophagy-inducing compound functioning by a hitherto unknown mechanism. Here, we confirm its autophagy-inducing effect by assessing classical autophagy-related parameters. Interestingly, we also discovered several additional effects of SMER28,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140127/ https://www.ncbi.nlm.nih.gov/pubmed/35626685 http://dx.doi.org/10.3390/cells11101648 |
_version_ | 1784715022594736128 |
---|---|
author | Kirchenwitz, Marco Stahnke, Stephanie Prettin, Silvia Borowiak, Malgorzata Menke, Laura Sieben, Christian Birchmeier, Carmen Rottner, Klemens Stradal, Theresia E. B. Steffen, Anika |
author_facet | Kirchenwitz, Marco Stahnke, Stephanie Prettin, Silvia Borowiak, Malgorzata Menke, Laura Sieben, Christian Birchmeier, Carmen Rottner, Klemens Stradal, Theresia E. B. Steffen, Anika |
author_sort | Kirchenwitz, Marco |
collection | PubMed |
description | SMER28 (Small molecule enhancer of Rapamycin 28) is an autophagy-inducing compound functioning by a hitherto unknown mechanism. Here, we confirm its autophagy-inducing effect by assessing classical autophagy-related parameters. Interestingly, we also discovered several additional effects of SMER28, including growth retardation and reduced G1 to S phase progression. Most strikingly, SMER28 treatment led to a complete arrest of receptor tyrosine kinase signaling, and, consequently, growth factor-induced cell scattering and dorsal ruffle formation. This coincided with a dramatic reduction in phosphorylation patterns of PI3K downstream effectors. Consistently, SMER28 directly inhibited PI3Kδ and to a lesser extent p110γ. The biological relevance of our observations was underscored by SMER28 interfering with InlB-mediated host cell entry of Listeria monocytogenes, which requires signaling through the prominent receptor tyrosine kinase c-Met. This effect was signaling-specific, since entry of unrelated, gram-negative Salmonella Typhimurium was not inhibited. Lastly, in B cell lymphoma cells, which predominantly depend on tonic signaling through PI3Kδ, apoptosis upon SMER28 treatment is profound in comparison to non-hematopoietic cells. This indicates SMER28 as a possible drug candidate for the treatment of diseases that derive from aberrant PI3Kδ activity. |
format | Online Article Text |
id | pubmed-9140127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91401272022-05-28 SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta Kirchenwitz, Marco Stahnke, Stephanie Prettin, Silvia Borowiak, Malgorzata Menke, Laura Sieben, Christian Birchmeier, Carmen Rottner, Klemens Stradal, Theresia E. B. Steffen, Anika Cells Article SMER28 (Small molecule enhancer of Rapamycin 28) is an autophagy-inducing compound functioning by a hitherto unknown mechanism. Here, we confirm its autophagy-inducing effect by assessing classical autophagy-related parameters. Interestingly, we also discovered several additional effects of SMER28, including growth retardation and reduced G1 to S phase progression. Most strikingly, SMER28 treatment led to a complete arrest of receptor tyrosine kinase signaling, and, consequently, growth factor-induced cell scattering and dorsal ruffle formation. This coincided with a dramatic reduction in phosphorylation patterns of PI3K downstream effectors. Consistently, SMER28 directly inhibited PI3Kδ and to a lesser extent p110γ. The biological relevance of our observations was underscored by SMER28 interfering with InlB-mediated host cell entry of Listeria monocytogenes, which requires signaling through the prominent receptor tyrosine kinase c-Met. This effect was signaling-specific, since entry of unrelated, gram-negative Salmonella Typhimurium was not inhibited. Lastly, in B cell lymphoma cells, which predominantly depend on tonic signaling through PI3Kδ, apoptosis upon SMER28 treatment is profound in comparison to non-hematopoietic cells. This indicates SMER28 as a possible drug candidate for the treatment of diseases that derive from aberrant PI3Kδ activity. MDPI 2022-05-16 /pmc/articles/PMC9140127/ /pubmed/35626685 http://dx.doi.org/10.3390/cells11101648 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kirchenwitz, Marco Stahnke, Stephanie Prettin, Silvia Borowiak, Malgorzata Menke, Laura Sieben, Christian Birchmeier, Carmen Rottner, Klemens Stradal, Theresia E. B. Steffen, Anika SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta |
title | SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta |
title_full | SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta |
title_fullStr | SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta |
title_full_unstemmed | SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta |
title_short | SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta |
title_sort | smer28 attenuates pi3k/mtor signaling by direct inhibition of pi3k p110 delta |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140127/ https://www.ncbi.nlm.nih.gov/pubmed/35626685 http://dx.doi.org/10.3390/cells11101648 |
work_keys_str_mv | AT kirchenwitzmarco smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT stahnkestephanie smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT prettinsilvia smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT borowiakmalgorzata smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT menkelaura smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT siebenchristian smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT birchmeiercarmen smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT rottnerklemens smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT stradaltheresiaeb smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta AT steffenanika smer28attenuatespi3kmtorsignalingbydirectinhibitionofpi3kp110delta |